166 related articles for article (PubMed ID: 28560456)
1. Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.
Ren Y; Liu F; Shi X; Geng T; Yuan D; Wang L; Kang L; Jin T; Chen C
Mol Med Rep; 2017 Jul; 16(1):573-580. PubMed ID: 28560456
[TBL] [Abstract][Full Text] [Related]
2. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.
Geng T; Zhang XY; Wang L; Wang H; Shi X; Kang L; Hou P; Jin T
Xenobiotica; 2016; 46(6):542-7. PubMed ID: 26383175
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
Bilgen T; Tosun O; Luleci G; Keser I
Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
[TBL] [Abstract][Full Text] [Related]
5. Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.
Jin T; Zhang X; Geng T; Shi X; Wang L; Yuan D; Kang L
Mol Med Rep; 2016 Mar; 13(3):2117-23. PubMed ID: 26781306
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
7. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of CYP1A2, novel polymorphisms and haplotypes in three distinct Asian populations.
Lim JS; Singh O; Ramasamy RD; Ramasamy S; Subramanian K; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2010; 25(6):616-23. PubMed ID: 20930417
[TBL] [Abstract][Full Text] [Related]
9. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
Skarke C; Kirchhof A; Geisslinger G; Lötsch J
Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
Woo SW; Kang TS; Park HJ; Lee JE; Roh J
J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
[TBL] [Abstract][Full Text] [Related]
11. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2 polymorphism (C > A at position -163) in Ovambos, Koreans and Mongolians.
Fujihara J; Shiwaku K; Xue Y; Kataoka K; Hieda Y; Takeshita H
Cell Biochem Funct; 2007; 25(5):491-4. PubMed ID: 16933202
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.
Zhang X; Meng X; Wang Y; Yan W; Yang J
Biochem Genet; 2012 Dec; 50(11-12):967-77. PubMed ID: 22983686
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.
Kohlrausch FB; Carracedo Á; Hutz MH
Mol Biol Rep; 2014 Mar; 41(3):1453-60. PubMed ID: 24443221
[TBL] [Abstract][Full Text] [Related]
15. CYP gene family variants as potential protective factors in drug addiction in Han Chinese.
Zhang H; Yang Q; Zheng W; Ouyang Y; Yang M; Wang F; Jin T; Zhang J; Wang Z
J Gene Med; 2016 Aug; 18(8):147-53. PubMed ID: 27257124
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
Chen L; Qin S; Xie J; Tang J; Yang L; Shen W; Zhao X; Du J; He G; Feng G; He L; Xing Q
Pharmacogenomics; 2008 Jun; 9(6):691-702. PubMed ID: 18518848
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
[TBL] [Abstract][Full Text] [Related]
18. CYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum.
Ma KF; Zhang XG; Jia HY
Genet Mol Res; 2014 Jul; 13(3):5637-43. PubMed ID: 25117321
[TBL] [Abstract][Full Text] [Related]
19. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
Uslu A; Ogus C; Ozdemir T; Bilgen T; Tosun O; Keser I
BMB Rep; 2010 Aug; 43(8):530-4. PubMed ID: 20797314
[TBL] [Abstract][Full Text] [Related]
20. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis.
Tian DD; Natesan S; White JR; Paine MF
Clin Transl Sci; 2019 Jan; 12(1):39-46. PubMed ID: 30387917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
